Aplex Bio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $781K

  • Investors
  • 5

Aplex Bio General Information

Description

Developer of a hyperplexed molecular detection technology designed to analyze a large number of biomarkers in vitro and in situ. The company's technology utilizes nano and biochemistry to facilitate applications from research to mass-scale in-vitro and precision diagnostics, enabling doctors to achieve parallelized detection of biomarkers easily and cost-efficiently.

Contact Information

Website
www.aplex.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Nobels Väg 16
  • 171 65 Solna
  • Sweden
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • Nobels Väg 16
  • 171 65 Solna
  • Sweden

Aplex Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aplex Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Seed Round 31-Dec-2023 $781K Completed Generating Revenue
6. Grant 22-Aug-2023 Completed Generating Revenue
5. Seed Round 31-Dec-2022 Completed Generating Revenue
4. Seed Round 11-Mar-2022 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2021 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Aplex Bio’s complete valuation and funding history, request access »

Aplex Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 3,287 $66.34 $66.34 1x $66.34 7.78%
Ordinary 5,713 $66.05 $66.05 1x $66.05 13.52%
To view Aplex Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Aplex Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a hyperplexed molecular detection technology designed to analyze a large number of biomarkers in vitro and
Biotechnology
Solna, Sweden
12 As of 2023

Madison, WI
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aplex Bio Competitors (2)

One of Aplex Bio’s 2 competitors is Exact Sciences, a Formerly VC-backed company based in Madison, WI.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Exact Sciences Formerly VC-backed Madison, WI
Volastra Venture Capital-Backed New York, NY
You’re viewing 2 of 2 competitors. Get the full list »

Aplex Bio Patents

Aplex Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4522770-A1 Methods and kits for detection of targets using pcr and padlock probes Pending 12-May-2022
US-20250223631-A1 Methods and kits for detection of targets using pcr and padlock probes Pending 12-May-2022
WO-2023218068-A1 Methods and kits for detection of targets using pcr and padlock probes Inactive 12-May-2022
US-20240418711-A1 New nanoparticles for use in the detection of target biomolecules Pending 06-Oct-2021
WO-2023057582-A1 New nanoparticles for use in the detection of target biomolecules Inactive 06-Oct-2021 G01N33/54346
To view Aplex Bio’s complete patent history, request access »

Aplex Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aplex Bio Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Vinnova Government
E14 Invest Angel Group Minority
Nordic Mentor Network For Entrepreneurship Accelerator/Incubator
DRIVE (KI Innovations Business Incubator) Accelerator/Incubator
Expara VirTech Global Accelerator Accelerator/Incubator Minority
To view Aplex Bio’s complete investors history, request access »

Aplex Bio FAQs

  • When was Aplex Bio founded?

    Aplex Bio was founded in 2020.

  • Where is Aplex Bio headquartered?

    Aplex Bio is headquartered in Solna, Sweden.

  • What is the size of Aplex Bio?

    Aplex Bio has 12 total employees.

  • What industry is Aplex Bio in?

    Aplex Bio’s primary industry is Biotechnology.

  • Is Aplex Bio a private or public company?

    Aplex Bio is a Private company.

  • What is the current valuation of Aplex Bio?

    The current valuation of Aplex Bio is .

  • What is Aplex Bio’s current revenue?

    The current revenue for Aplex Bio is .

  • How much funding has Aplex Bio raised over time?

    Aplex Bio has raised $2.2M.

  • Who are Aplex Bio’s investors?

    Vinnova, E14 Invest, Nordic Mentor Network For Entrepreneurship, DRIVE (KI Innovations Business Incubator), and Expara VirTech Global Accelerator have invested in Aplex Bio.

  • Who are Aplex Bio’s competitors?

    Exact Sciences and Volastra are competitors of Aplex Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process